FDA 483 - Lupin Limited - September 20, 2019

Lupin Limited in Tarapur, India, an API manufacturer, was cited with three observations during an FDA inspection. The observations primarily concern inadequate investigations into discrepancies, deficiencies in batch production and control records, and improper handling and storage of cleaned utensils, indicating significant issues with quality control and contamination prevention.